ANGLE Announces Collaboration with Myriad Genetics

About this update from Myriad Genetics, Inc.

[{"type":"text","content":"Assessment of feasibility for use of Parsortix derived circulating tumour cell (CTC) DNA with Myriad Genetics' existing tissue-based diagnostic test","length":152,"tagName":"p"},{"type":"text","content":"GUILDFORD, SURREY / ACCESS Newswire / August 20, 2025 / ANGLE plc (AIM:AGL)(OTCQX:ANPCY), a world-leading liquid biopsy company with innovative circulating tumour cell (CTC) solutions for use in research, drug development and clinical oncology, is delighted to announce that it has entered a collaboration with Myriad Genetics, Inc. (MYGN:NSQ), a leading molecular diagnostic testing and precision medicine company dedicated to advancing health and well-being for all.","length":468,"tagName":"p"},{"type":"text","content":"Under the terms of the agreement, blood samples from cancer patients will be processed by ANGLE's research and development team utilising the Parsortix® system for the capture and harvest of intact cancer cells for downstream molecular analysis. Results for this analysis will compare CTC-DNA with matched patient tissue samples using Myriad Genetics' existing tissue-based assay.","length":388,"tagName":"p"},{"type":"text","content":"Further details of the agreement are confidential between the parties.","length":70,"tagName":"p"},{"type":"text","content":"ANGLE Chief Executive, Andrew Newland, commented:","length":49,"tagName":"p"},{"type":"text","content":""We are delighted to be working with Myriad Genetics, a major player in tissue-based companion diagnostic tests, seeking to extend their tests to work on a simple blood test using CTCs harvested by the Parsortix system. We look forward to working with Myriad Genetics to progress this collaboration which has the potential to have a substantial impact on patient treatment by improving access to actionable genomic data."","length":431,"tagName":"p"},{"type":"text","content":"For further information:","length":24,"tagName":"p"},{"type":"table","headerItems":[],"items":[{"val":[{"style":"padding:.25pt 5.65pt;vertical-align:top;width:259.15pt;","val":[{"type":"text","content":"ANGLE plc","length":9,"tagName":"p","attribs":{}}]},{"style":"padding:.25pt 5.65pt;vertical-align:top;width:172.05pt;","val":[{"type":"text","content":"+44 (0) 1483 343434","length":19,"tagName":"p","attribs":{}}]}]},{"val":[{"style":"padding:.25pt 5.65pt;vertical-align:top;...

More updates from Myriad Genetics, Inc.